International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

A. Palumbo; O. Sezer; R. Kyle; J. S. Miguel; R. Z. Orlowski; P. Moreau; R. Niesvizky; G. Morgan; R. Comenzo; P. Sonneveld; S. Kumar; R. Hajek; S. Giralt; S. Bringhen; K. C. Anderson; P. G. Richardson; M. Cavo; F. Davies; J. Blade; H. Einsele; M. A. Dimopoulos; A. Spencer; A. Dispenzieri; T. Reiman; K. Shimizu; J. H. Lee; M. Attal; M. Boccadoro; M. Mateos; W. Chen; H. Ludwig; D. Joshua; J. Chim; V. Hungria; Ingemar Turesson; B. G. M. Durie; S. Lonial

doi:10.1038/leu.2009.122

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

A. Palumbo, O. Sezer, R. Kyle, J. S. Miguel, R. Z. Orlowski, P. Moreau, R. Niesvizky, G. Morgan, R. Comenzo, P. Sonneveld, S. Kumar, R. Hajek, S. Giralt, S. Bringhen, K. C. Anderson, P. G. Richardson, M. Cavo, F. Davies, J. Blade, H. EinseleM. A. Dimopoulos, A. Spencer, A. Dispenzieri, T. Reiman, K. Shimizu, J. H. Lee, M. Attal, M. Boccadoro, M. Mateos, W. Chen, H. Ludwig, D. Joshua, J. Chim, V. Hungria, Ingemar Turesson, B. G. M. Durie, S. Lonial

Department of Clinical Sciences, Malmö

Research output: Contribution to journal › Review article › peer-review

Abstract

In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM. Leukemia (2009) 23, 1716-1730; doi: 10.1038/leu.2009.122; published online 4 June 2009

Original language	English
Pages (from-to)	1716-1730
Journal	Leukemia
Volume	23
Issue number	10
DOIs	https://doi.org/10.1038/leu.2009.122
Publication status	Published - 2009

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Subject classification (UKÄ)

Cancer and Oncology

Free keywords

chemotherapy
treatment
myeloma
guidelines

Access to Document

10.1038/leu.2009.122

Cite this

Palumbo, A., Sezer, O., Kyle, R., Miguel, J. S., Orlowski, R. Z., Moreau, P., Niesvizky, R., Morgan, G., Comenzo, R., Sonneveld, P., Kumar, S., Hajek, R., Giralt, S., Bringhen, S., Anderson, K. C., Richardson, P. G., Cavo, M., Davies, F., Blade, J., ... Lonial, S. (2009). International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia, 23(10), 1716-1730. https://doi.org/10.1038/leu.2009.122

@article{2dc779ed406a427fa6db56b877345ce3,

title = "International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation",

abstract = "In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM. Leukemia (2009) 23, 1716-1730; doi: 10.1038/leu.2009.122; published online 4 June 2009",

keywords = "chemotherapy, treatment, myeloma, guidelines",

author = "A. Palumbo and O. Sezer and R. Kyle and Miguel, \{J. S.\} and Orlowski, \{R. Z.\} and P. Moreau and R. Niesvizky and G. Morgan and R. Comenzo and P. Sonneveld and S. Kumar and R. Hajek and S. Giralt and S. Bringhen and Anderson, \{K. C.\} and Richardson, \{P. G.\} and M. Cavo and F. Davies and J. Blade and H. Einsele and Dimopoulos, \{M. A.\} and A. Spencer and A. Dispenzieri and T. Reiman and K. Shimizu and Lee, \{J. H.\} and M. Attal and M. Boccadoro and M. Mateos and W. Chen and H. Ludwig and D. Joshua and J. Chim and V. Hungria and Ingemar Turesson and Durie, \{B. G. M.\} and S. Lonial",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)",

year = "2009",

doi = "10.1038/leu.2009.122",

language = "English",

volume = "23",

pages = "1716--1730",

journal = "Leukemia",

issn = "1476-5551",

publisher = "Nature Publishing Group",

number = "10",

}

Palumbo, A, Sezer, O, Kyle, R, Miguel, JS, Orlowski, RZ, Moreau, P, Niesvizky, R, Morgan, G, Comenzo, R, Sonneveld, P, Kumar, S, Hajek, R, Giralt, S, Bringhen, S, Anderson, KC, Richardson, PG, Cavo, M, Davies, F, Blade, J, Einsele, H, Dimopoulos, MA, Spencer, A, Dispenzieri, A, Reiman, T, Shimizu, K, Lee, JH, Attal, M, Boccadoro, M, Mateos, M, Chen, W, Ludwig, H, Joshua, D, Chim, J, Hungria, V, Turesson, I, Durie, BGM & Lonial, S 2009, 'International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation', Leukemia, vol. 23, no. 10, pp. 1716-1730. https://doi.org/10.1038/leu.2009.122

TY - JOUR

T1 - International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

AU - Palumbo, A.

AU - Sezer, O.

AU - Kyle, R.

AU - Miguel, J. S.

AU - Orlowski, R. Z.

AU - Moreau, P.

AU - Niesvizky, R.

AU - Morgan, G.

AU - Comenzo, R.

AU - Sonneveld, P.

AU - Kumar, S.

AU - Hajek, R.

AU - Giralt, S.

AU - Bringhen, S.

AU - Anderson, K. C.

AU - Richardson, P. G.

AU - Cavo, M.

AU - Davies, F.

AU - Blade, J.

AU - Einsele, H.

AU - Dimopoulos, M. A.

AU - Spencer, A.

AU - Dispenzieri, A.

AU - Reiman, T.

AU - Shimizu, K.

AU - Lee, J. H.

AU - Attal, M.

AU - Boccadoro, M.

AU - Mateos, M.

AU - Chen, W.

AU - Ludwig, H.

AU - Joshua, D.

AU - Chim, J.

AU - Hungria, V.

AU - Turesson, Ingemar

AU - Durie, B. G. M.

AU - Lonial, S.

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)

PY - 2009

Y1 - 2009

N2 - In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM. Leukemia (2009) 23, 1716-1730; doi: 10.1038/leu.2009.122; published online 4 June 2009

AB - In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM. Leukemia (2009) 23, 1716-1730; doi: 10.1038/leu.2009.122; published online 4 June 2009

KW - chemotherapy

KW - treatment

KW - myeloma

KW - guidelines

UR - https://www.scopus.com/pages/publications/70350094381

U2 - 10.1038/leu.2009.122

DO - 10.1038/leu.2009.122

M3 - Review article

C2 - 19494840

SN - 1476-5551

VL - 23

SP - 1716

EP - 1730

JO - Leukemia

JF - Leukemia

IS - 10

ER -

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

Abstract

Bibliographical note

UN SDGs

Subject classification (UKÄ)

Free keywords

Access to Document

Other files and links

Fingerprint

Cite this